Latest data from October 8, 2021
Number of Health Center respondents = 13 (76% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 1,796 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 53.36% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 402 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 41.74% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 44.43% | 35.07% |
| White, Hispanic/Latino Patients | 7.24% | 1.24% |
| Black/African American, Non-Hispanic/Latino Patients | 28.45% | 13.68% |
| Black/African American, Hispanic/Latino Patients | 0.95% | 1.00% |
| Asian Patients3 | 1.06% | 1.74% |
| American Indian/Alaska Native Patients3 | 1.78% | 0.25% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% | 0.00% |
| Patients with More than one race3 | 6.85% | 5.72% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 4.51% | 1.49% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 2.84% | 5.47% |
| Unreported/Refused to Report Race and Ethnicity | 1.89% | 34.33% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 328 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 77.20% |
| COVID-19 Immunization Series Completed | 350 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 82.46% |
| COVID-19 Immunization Series Additional | 68 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 66.67% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 21.34% | 17.14% | 32.35% |
| White, Hispanic/Latino Patients | 5.49% | 4.86% | 1.47% |
| Black/African American, Non-Hispanic/Latino Patients | 43.29% | 43.43% | 47.06% |
| Black/African American, Hispanic/Latino Patients | 4.27% | 7.14% | 1.47% |
| Asian Patients3 | 5.49% | 5.14% | 7.35% |
| American Indian/Alaska Native Patients3 | 0.30% | 1.43% | 1.47% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.91% | 0.86% | 0.00% |
| Patients with More than one race3 | 3.96% | 3.14% | 4.41% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 8.54% | 14.57% | 1.47% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.66% | 2.29% | 1.47% |
| Unreported/Refused to Report Race and Ethnicity | 2.74% | 0.00% | 1.47% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 23.08% |
| 1 to 24 Hours | 30.77% |
| More Than 24 Hours | 30.77% |
| N/A | 15.38% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 0.00% |
| Staffing to administer the vaccine | 38.46% |
| Vaccine confidence | 23.08% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 30.77% |
| None | 23.08% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 38.46% |
| Average Percent of Health Center Visits Conducted Virtually | 20.77% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 23.08% |
| Number of Mobile Van Sites | 1 |
| Number of Pop-up Clinics | 2 |
| Number of School-Based Vaccination Sites | 5 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 0.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 76.92% |
| None | 23.08% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 7.69% |
| Patient awareness/education | 15.38% |
| Staffing capacity | 7.69% |
| Therapy administration/onsite logistics | 7.69% |
| Other | 7.69% |
| None | 76.92% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
